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Abstract 
INTRODUCTION: Colorectal liver metastases have a poor prognosis, and only 2% have an average 5-year 
survival if left untreated. Despite radical resection, the average five-year survival is between 25% and 44%. 
AIM: To explore the experience of the Clinic in the treatment of colorectal liver metastases, comparing it with data 
from the literature and based on the comparison to determine the influence of the type and extensity of resection 
survival after radical surgical treatment of patients. 
METHODS: This is a retrospective study. The study comprised the period between 01.01.2006 to 31.12.2015. It 
included a total of 239 cases, of whom: 179 patients underwent radical interventions, 5 palliative and 55 patients 
underwent explorative interventions due to liver metastases. 
RESULTS: Radical resection of liver metastases has the impact of the patient survival, and the survival is the 
smallest in the patients with left hemihepatectomy and the longest in the patients with bisegmentectomy. But no 
specific technique and the number of resected segments influenced the survival of patients with colorectal liver 
metastases. 
CONCLUSION: In patients with colorectal liver metastases only resection has potentially curative character. The 
type and amount of liver resection has no influence of the survival. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Colorectal cancer (CRC) is the third most 
common cancer worldwide after lung cancer and 
breast cancer [1] [2]. A large percentage of 50-70% of 
patients develops colorectal liver metastases (CRLM) 
because of hematogenous dissemination of primary 
cancer [3] [4] [5] [6] [7]. Synchronous metastases are 
diagnosed in 15-25% [8] [9] [10] during the primary 
diagnosis of CRC and in 20-25% [11] [12] [13] [14] 
[15] in the first five years metachronous metastases 
develop. They represent the most common cause of 
death so that 77% of untreated patients die in the first 
year, and only 14-23% survive more than three years 
[16] [17] [18] [19]. Surgical resection represents the 
only curative treatment approach to patients with 
CRLM; in larger series patients treated with resection 
have a mean 5-year survival from 25% to 44% [15] 
[20] [21], but only 15-25% [22] of metastasis of liver 
are initially resectable. Poor prognosis of the disease 
is the cause of looking for opportunities to improve 
postoperative results which correspond with defining 
determinants of survival. 
To explore our experience in the treatment of 
colorectal liver metastases (CRLM), comparing them 
with data from the literature, and based on the 
comparison to determine the influence of type and 
amount of resection of the survival after radical 
surgical treatment of patients. 
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Material and Methods 
 
A retrospective study was conducted at the 
Clinic of General and Hepato-pancreatic surgery at 
the University Hospital "Aleksandrovska" – Sofia, 
Bulgaria. The study comprised the period between 
01.01.2006 to 31.12.2015. It included a total of 239 
patients, of whom: 179 patients (74.9%) underwent 
radical interventions (atypical resection - 57, resection 
of 2 segments - 24, resection of 3 segments - 18, 
resection of >3 segments - 10, left lobectomy - 15, left 
hemihepatectomy - 4, right hemihepatectomy - 12, 
metastasectomy - 20, resection with another 
procedure - 19, atypical resection and 
metastasectomy - 9, left lobectomy and atypical 
resection - 5, atypical resection and alcoholization - 1, 
atypical resection and thermoablation - 4; and 5 
palliative and 55 patients underwent explorative 
interventions due to liver metastases (biopsy - 55, 
biopsy and biliary drainage - 2, thermoablation - 1, 
alcoholization - 2). Also, 119 (49.8%) patients were 
diagnosed with synchronous metastases, 120 (50.2%) 
patients with metachronous metastases, including 7 
(2.9%) with metachronous metastases with 
recurrence on the colon.  
The follow-up period of the patients operated 
on for colorectal liver metastases in the Clinic was 5 
years after resection of the liver. 
The study included all patients with liver 
metastases from colorectal cancer regardless of their 
age and gender; 
The study included all patients with liver 
metastases from colorectal cancer: synchronous 
metastases, metachronous metastases and 
metastases appearing with local recurrence of cancer; 
The endpoints were to determine the 
following: 
1. Survival depending on the type of surgical 
intervention: radical surgery or the palliative surgery or 
biopsy; 
2. Cumulative overall survival depending on 
the type of the surgical intervention: radical surgery or 
the palliative surgery or biopsy; 
3. To assess whether the specific type of 
radical hepatic resection has an influence on mortality 
(atypical resection, 2 - segment resection, resection of 
more than 3 segments, left - lobectomy, left 
hemihepatectomy, right hemihepatectomy, 
metastasectomy, combined liver surgery) as well as 
on median survival; 
4. To assess whether the specific type of 
palliative intervention (biopsy, thermoablation, 
alcoholization) has an influence on mortality as well as 
on survival; 
5. To assess whether the volume of liver 
resection (small and large resection) has an influence 
on mortality as well as on median survival. 
Statistical analysis of the collected material to 
determine the factors for survival was done using the 
SPSS-19 statistical program.  
 
 
Results 
 
The average survival of patients undergoing 
radical intervention is about three times longer than 
that of palliative care. The Logging and Breslow 
statistical tests, as well as the regression analysis, 
confirm that the type of operative intervention involved 
is a significant factor in the survival of patients with 
this pathology (Figure 1). 
 
Figure 1: Survival curves depending on the type of surgical 
intervention; Log Rank (Mantel-Cox) p < 0.0001; Breslow p < 
0.0001 
 
Patients undergoing radical surgery are 
associated with a 79.7% lower risk of lethal outcome 
than patients with palliative care or patients who 
underwent biopsy (Table 1, 2). 
Table 1: Cumulative overall survival depending on the type of 
the surgical intervention 
Type of operation Deaths Cumulative survival % ( Std.Error) 
N (%) 1-year 3-year 5-year 
Radical 131 (78.44) 89.2 (0.028) 32.4 (0.04) 24.1 (0.03) 
Palliative / biopsy 38 (92.68) 53.8 (0.08) 0 0 
 
To assess whether the specific volume and 
type of radical hepatic resection influence survival, we 
analysed the data from the patients we follow.  
Table 2: Cox regression analysis according to the applied 
surgical intervention 
 p Exp (B) 95% CI for  Exp (B) 
Reference category-palliative intervention/biopsy 
Radical intervention <0.0001 0.203 0.135-0.306 
 
 The distribution of established deaths for 
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patients over the study period treated with radical 
surgery depending on the type of resection is as 
follows: - 64.15% mortality in patients with atypical 
resection (34/53 patients); - 68.18% in the 2-segment 
resection group (15/22 patients); - 100% mortality was 
recorded in resection of more than 3 segments (8/8 
patients); - 86.67% of left-lobectomy patients died in 
the follow-up (13/15 patients); - 100% of those with 
left hemi-hepatectomy (3/3 patients); - 91.67% of 
patients with right hemi-hepatectomy (11/12 patients) 
and 85% of cases with metastasectomy (17/20 
patients). 
In patients undergoing combined liver 
surgery, 83.33% of the patients were with fatal 
outcome. 
Survival analysis revealed that median 
survival was lowest in the left hemi-hepatectomy 
group (about 14 months), and the highest in patients 
with two-segment resection (48 months).  
Table 3: Mean and median survival based on the type of liver 
resection applied 
Type of resection Mean and median survival 
Mean Std.err 95% CI Median Std.err 95% CI 
Atypical resection 40.565 4.026 32.675-
48.456 
35.0 6.525 22.211-
47.789 
Resection of 2 
segments 
48.229 7.39 33.744-
62.714 
36.0 11.38 13.69-58.31 
Resection of 3 
segments 
28.125 5.204 17.924-
38.326 
22.0 14.0 0.000-49.44 
Resection of more 
than 3 segments 
31.125 7.391 16.639-
45.611 
28.0 11.314 5.825-
50.175 
Left lobectomy 32.214 5.451 21.53-
42.898 
26.0 1.852 22.371-
29.629 
Left hemi-
hepatectomy 
13.667 1.333 11.053-
16.28 
15.0 0.0  
Right hemi-
hepatectomy 
24.476 2.455 19.665-
29.287 
22.0 3.143 15.839-
28.161 
Metastasectomy 40.047 7.076 26.178-
53.915 
32.0 8.876 14.603-
49.397 
Resection + other 
procedure 
26.063 4.093 18.041-
34.085 
26.0 2.91 20.297-
31.703 
 
This difference is statistically significant (P = 
0.004, P = 0.043), but when comparing all methods 
used, no "best" surgical method for treating CRLMs 
(Table 3, Figure 2). 
 
Figure 2:    Survival curves depending on the type of resection; Log 
Rank (Mantel-Cox) P = 0.004**; Breslow P = 0.043*; *P < 0.05; **P 
< 0.01 
In regression analysis, none of the operative 
techniques showed an advantage as a predictor of 
survival (Table 4). 
Table 4: Cox regression analysis according to the type of liver 
resection applied 
Type of resection p Exp (B) 95% CI for  Exp (B) 
Reference category – other types of resection 
Atypical resection 0.237 0.788 0.531-1.169 
Resection of 2 segments 0.053 0.583 0.337-1.006 
Resection of 3 segments 0.28 1.348 0.784-2.316 
Resection of more than 3 
segments 
0.378 1.383 0.673-2.839 
Left lobectomy 0.524 1.206 0.678-2.147 
Right hemi-hepatectomy 0.114 1.661 0.885-3.116 
metastasectomy 0.299 0.755 0.444-1.284 
Resection + other procedure 0.113 1.555 0.901-2.685 
 
The mortality analysis after a palliative 
intervention or biopsy showed that in this group the 
mortality was 94.87% of the patients. Only the patient 
who has been subjected to thermoablation is alive 
from the group of palliative patients. The Kaplan-Meier 
method of survival was examined according to the 
type of palliative intervention performed in figure 3. 
 
Figure 3: Survival curves depending on the type of palliative 
intervention 
 
As can be seen from the graph and the 
additional regression analysis (Table 5), the 
application of biopsy or palliative intervention due to 
the inability to perform a radical intervention in CRLM 
patients significantly degrades long-term treatment 
outcomes. The fact that adjuvant therapy has been 
administered in most of these patients, and yet the 
average survival rate is significantly lower than that of 
the radically-operated patients, again proves the key 
role of surgical resection in the treatment of these 
patients. 
Table 5: Cox regression analysis using palliative methods of 
treatment 
Type of palliative operations p Exp (B) 95% CI for  Exp (B) 
Reference category-other palliative interventions 
Biopsy 0.153 0.22 0.027-1.756 
 
Survival analysis was also performed 
according to the volume of surgery. In the group of 
patients undergoing large liver resection, 87 people 
(78.38%) died on long-term follow-up.  
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Table 6: Mean and median survival based on the volume of 
liver resection 
Volume of the 
operation 
Mean and median survival 
Mean Std.err 95% CI Median Std.err 95% CI 
Big 31.042 2.043 27.037-
35.047 
26.0 1.84 22.393-
29.607 
Small 31.283 3.078 25.249-
37.316 
18.0 1.515 15.03-20.97 
 
A fatal outcome was found in 82 (84.54%) 
patients with a small volume of hepatic intervention. 
The average survival in both groups is about 31 
months (Table 6, Figure 4). 
 
Figure 4: Survival curves depending on the volume of liver resection; Lоg 
Rank (Mantel-Cox) P = 0.796; Breslow P = 0.12 
 
The additional analysis of the results (Cox 
regression) did not establish a significant correlation 
between the volume of surgical intervention according 
to the number of resected liver segments and the 
survival in patients with CRLM (Table 7). 
Table 7: Cox regression analysis (Univariate analysis) 
concerning the volume of liver resection 
Volume of operation p Exp (B) 95% CI for Exp (B) 
Reference category-Big 
small 0.8 1.041 0.762-1.424 
 
 
Discussion 
 
This retrospective study showed a significant 
difference in the survival of patients operated 
radically. Survival of patients OS operated with non-
anatomical resection NAR is no different from the 
survival of patients treated with AR. Also, the 
difference in patient survival is identified as 
significantly larger in the group of small resections, but 
this does not set the number of resected segments as 
a survival factor. Anatomical resection provides better 
cleaning between tumor deposits and the liver 
transaction line and is recommended as a standard 
procedure for metastatic liver tumor [24]. Non-
anatomical resection is useful in small metastases, 
with little risk of microscopic local invasion [23]. Non-
anatomical resection NAR has become more 
commonly used in view of the possibility of storing a 
larger volume of hepatic parenchyma, but the NAR 
compared to AR is associated with a higher incidence 
of positive resection ranges (R1 resection) [25]. 
Consensus has been widely accepted that a positive 
surgical margin is a powerful predictor of patient 
survival and recurrence [32] [33] [34]. As has been 
reported, the rate for five-year survival ranges only 
from 17.1% to 20% for patients with positive margins 
compared with that ranging from 37% to 63.8% with 
negative margins [32] [33]. As to median survival, the 
median length was 23 months for patients with 
positive margins, less than 45 months with negative 
margins [33]. Besides, overall recurrence rates were 
significantly different between patients with positive 
margins and with negative margins (51.1% and 
38.6%, respectively) [33]. Studies show that the type 
of resection (anatomic or non-anatomic) is irrelevant 
for postoperative morbidity and mortality, with both 
negative histological margins (R0 resection) being 
achieved [25] [26] [27] [28] [29]. The use of non-
anatomical resection has certain advantages such as 
lower blood loss, significant shorter operating times 
and shorter duration of hospital treatment [25] [26] 
[28]. As previously reported [35] [36] [37], AR 
featuring higher level of surgical technique difficulty 
would often be associated with longer operation 
duration and more liver parenchyma loss. Bile 
leakage, wound infection and intra-abdominal 
collections constituting the major types of 
complications all show evident preferences to AR 
group over NAR group. Taken together, AR might 
promote the incidence of postoperative morbidity. The 
main cause for the inferiority of AR to NAR in terms of 
mortality is thought to be its larger loss of liver 
parenchyma. With more extensive parenchymal 
resection, AR would consequently carry a more 
substantial risk. As reported by Lalmahomed ZS [28], 
postoperative hepatic failure resulting from 
insufficiency of liver remnant was the primary cause of 
mortality in AR group. But the type of resection of the 
liver does not affect the survival of patients with 
CRLMs.  
Zorzi et al., [26] report a 5-year survival rate 
of 61% in favour of the NAR and 60% in the case of 
AR. Guzzetti et al., [30] -5-year survival of 29% for the 
NAR and 27% for AR. Many studies find that the type 
and extensity of the resection don’t influence the 
survival, but blood loss is crucial as a factor of 
postoperative morbidity and mortality [31]. Also, other 
factors of survival such a type, number, size, and 
localisation correspond with the type and the extensity 
of resection of liver and also have the implication of 
long-term survival. To conclude that the patients 
treated with NAR and AR have similar OS survival of 
the patients with colorectal liver metastases. Also, the 
amount of the liver resection sometimes is crucial for 
the surgical strategy, and it has implications for the 
postoperative morbidity and mortality, but it isn’t a 
factor of long-term survival.  
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